Interacción de Atorvastatina con Nefazodona

Atorvastatina con Nefazodona: ambas etiquetas de prescripción describen una interacción que por lo general requiere seguimiento, un cambio de dosis o espaciar las tomas.

Moderada

Por lo general, manejable con seguimiento o un cambio de dosis. Informe a su farmacéutico de que toma ambos.

Qué dicen las etiquetas de la FDA

De la etiqueta de Atorvastatina (Lipitor) · vigente desde 2024-04-15

Moderada

LIPITOR plasma levels can be significantly increased with concomitant administration of inhibitors of CYP3A4 and transporters.

Interacciones medicamentosaspor clase farmacológicaVer la etiqueta en DailyMed
Moderada

Table 2: Drug Interactions that may Increase the Risk of Myopathy and Rhabdomyolysis with LIPITOR Cyclosporine or Gemfibrozil Clinical Impact: Atorvastatin plasma levels were significantly increased with concomitant administration of LIPITOR and cyclosporine, an inhibitor of CYP3A4 and OATP1B1 [see Clinical Pharmacology (12.3) ] .

Interacciones medicamentosaspor clase farmacológicaVer la etiqueta en DailyMed
Moderada

Anti-Viral Medications Clinical Impact: Atorvastatin plasma levels were significantly increased with concomitant administration of LIPITOR with many anti-viral medications, which are inhibitors of CYP3A4 and/or transporters (e.g., BCRP, OATP1B1/1B3, P-gp, MRP2, and/or OAT2) [see Clinical Pharmacology (12.3) ] .

Interacciones medicamentosaspor clase farmacológicaVer la etiqueta en DailyMed

De la etiqueta de Nefazodona (Nefazodone Hydrochloride) · vigente desde 2025-07-31

Moderada

HMG-CoA Reductase Inhibitors – When single 40 mg doses of simvastatin or atorvastatin, both substrates of CYP3A4, were given to healthy adult volunteers who had received nefazodone hydrochloride, 200 mg BID for 6 days, approximately 20 fold increases in plasma concentrations of simvastatin and simvastatin acid and 3 to 4 fold increases in plasma concentrations…

Interacciones medicamentosaspor clase farmacológicaVer la etiqueta en DailyMed
Moderada

Rhabdomyolysis has been observed in patients receiving HMG-CoA reductase inhibitors administered alone (at recommended dosages) and in particular, for certain drugs in this class, when given in combination with inhibitors of the CYP3A4 isozyme.

Interacciones medicamentosaspor clase farmacológicaVer la etiqueta en DailyMed
Moderada

Caution should be used if nefazodone is administered in combination with HMG-CoA reductase inhibitors that are metabolized by CYP3A4, such as simvastatin, atorvastatin, and lovastatin, and dosage adjustments of these HMG-CoA reductase inhibitors are recommended.

Interacciones medicamentosaspor clase farmacológicaVer la etiqueta en DailyMed
Moderada

Since metabolic interactions are unlikely between nefazodone and HMG-CoA reductase inhibitors that undergo little or no metabolism by the CYP3A4 isozyme, such as pravastatin or fluvastatin, dosage adjustments should not be necessary.

Interacciones medicamentosaspor clase farmacológicaVer la etiqueta en DailyMed
Leve

This is consistent with the interactions observed between nefazodone and triazolam, alprazolam, buspirone, atorvastatin, and simvastatin, drugs metabolized by this isozyme.

Interacciones medicamentosasmenciona AtorvastatinaVer la etiqueta en DailyMed

¿Toma algo más además de estos dos? Las interacciones se acumulan. Compruebe toda su lista de una vez; se queda en su navegador.

Abrir en el verificador

No es un consejo médico. Interaction Checker cita el texto de las etiquetas de la FDA y las hojas informativas de los NIH. Que una interacción sea importante en su caso depende de las dosis, el momento de las tomas, la función renal y hepática y otras afecciones. Confírmelo con un farmacéutico o un prescriptor.